Clinical Trials on Platinum-Resistant Ovarian Carcinoma
Total 2616 results
-
NewVac LLCJanssen Pharmaceutica N.V., BelgiumCompletedOvarian CancerRussian Federation
-
Anhui Provincial HospitalUnknown
-
The Netherlands Cancer InstituteUnknown
-
Genentech, Inc.TerminatedOvarian CancerUnited States, Spain, Belgium, Canada, France, United Kingdom, Poland
-
Hellenic Oncology Research GroupCompletedOvarian CancerGreece
-
Genentech, Inc.Completed
-
North Eastern German Society of Gynaecological...CompletedOvarian Cancer
-
North Eastern German Society of Gynaecological...Completed
-
Genentech, Inc.Completed
-
Odense University HospitalUnknown
-
North Eastern German Society of Gynaecological...Completed
-
Cairo UniversityCompleted
-
University of ChicagoCompleted
-
Hoffmann-La RocheCompletedOvarian CancerFrance, Spain, Sweden, Hong Kong, Canada, Switzerland, Estonia, Greece, Russian Federation, Hungary, Austria, Bulgaria, Netherlands, Latvia, Italy, Slovenia, Turkey, Serbia, Israel, Argentina, Brazil, Slovakia, Lithuania, Poland, Portugal, Mexi... and more
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomCompleted
-
Pine Street FoundationCompletedOvarian CancerUnited States
-
Hillel Yaffe Medical CenterUnknown
-
National Cancer Institute, NaplesCompleted
-
Eventus Diagnostics LtdUnknown
-
Memorial Sloan Kettering Cancer CenterCompletedOvarian CancerUnited States
-
Asan Medical CenterUnknownOvarian CancerKorea, Republic of
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)Withdrawn
-
Massachusetts General HospitalNational Cancer Institute (NCI)UnknownOvarian CancerUnited States
-
University of OxfordUnknown
-
Neovii BiotechFresenius Biotech North AmericaCompletedOvarian CancerUnited States
-
Samyang Biopharmaceuticals CorporationCompleted
-
Ontario Clinical Oncology Group (OCOG)PfizerCompleted
-
Heidelberg UniversityUnknown
-
Weill Medical College of Cornell UniversityTerminated
-
CanariaBio Inc.TerminatedOvary Cancer | Ovarian Cancer Stage IV | Neoplasms, Ovarian | Ovarian Cancer Stage III | Ovarian Cancer Recurrent | Cancer of OvaryUnited States
-
M.D. Anderson Cancer CenterRecruitingOvarian Carcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Neoplasm | Low Grade Ovarian Serous Adenocarcinoma | Primary Peritoneal Low Grade Serous Adenocarcinoma | PsammocarcinomaUnited States
-
Fundacion Clinic per a la Recerca BiomédicaNot yet recruiting
-
University of MinnesotaCompletedFallopian Tube Cancer | Recurrent Ovarian Cancer | Stage IV Ovarian Cancer | Stage III Ovarian CancerUnited States
-
National Cancer Institute (NCI)CompletedRecurrent Ovarian Epithelial Cancer | Recurrent Primary Peritoneal Cavity CancerCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingOvarian CarcinomaUnited States
-
OncXerna Theraputics, Inc.Not yet recruitingOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Carcinoma
-
Fudan UniversityNot yet recruitingRecurrent Ovarian CancerChina
-
Women's Hospital School Of Medicine Zhejiang UniversityRecruiting
-
Cukurova UniversityRecruitingEpithelial Ovarian Cancer | Rectosigmoid Cancer MetastaticTurkey
-
Haukeland University HospitalHelse Stavanger HF; Sorlandet Hospital HFRecruiting
-
AstraZenecaParexel; Covance; Iqvia Pty Ltd; Theradex; Myriad Genetics, Inc.CompletedNon-Germline BRCA Mutated Ovarian CancerItaly, Spain, Sweden, Canada, Czechia, Poland, United Kingdom, Israel, Austria, Belgium, Switzerland, Netherlands, Bulgaria, Finland, Norway, Denmark, Slovenia, Portugal
-
AstraZenecaCompletedBRCA or HRR+ Mutated Ovarian Cancer PatientsItaly, Spain, Canada, Czechia, Poland, United Kingdom, Hungary, Bulgaria
-
Icahn School of Medicine at Mount SinaiWithdrawn
-
National Cancer Center, KoreaAjou UniversityCompletedEpithelial Ovarian CancerKorea, Republic of
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletedRecurrent Ovarian CancerChina
-
Montefiore Medical CenterNational Cancer Institute (NCI)CompletedOvarian Cancer | Peritoneal Cavity CancerUnited States
-
PEDRO VILLAREJO CAMPOSUniversity of Castilla-La Mancha; Hospital General de Ciudad RealUnknownEpithelial Ovarian CancerSpain
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Charite University, Berlin, GermanyWithdrawnRight Ventricular Function and Venous ReturnGermany